
About ubio
ubio is a Healthcare company based in Kochi (India) founded in 2008 by Bishor Ibrahim. Diagnostic products for medical, veterinary, and food uses are developed. Its Indian entity Ubio Biotechnology Systems Private Limited reported revenue of βΉ11.58 Cr. Its focus areas include Diversified Diagnostics and Tests.
Company details
ubio is a diagnostic company developing medical, veterinary and food diagnostics products. The company majorly focused on immunochromatographic based lateral flow devices. It has developed rapid test kits for infections (filariasis, thyroid, brucellosis, cholera, rotavirus, adenovirus, H. pyroli, HIV, Hepatitis), biomarkers hormones for the human. The company has also developed immunoassays for livestock poultry. The company is developing assays based on serology, biochemistry molecular diagnostics and diagnostic equipment. Also offering contract manufacturing, contract assay development consulting services for diagnostic applications.
- Headquarters Kochi, India
- Founders Bishor Ibrahim
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website ubio.in
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Ubio Biotechnology Systems Private Limited
- Date of Incorporation 23 Jul, 2008
- Jurisdiction Ernakulam, Kerala, India
- Annual Revenue₹11.58 Cr
FY 2024 · +66% YoY
- Net Profit₹16 Lakh
FY 2024 · 1% margin
- EBITDA₹1.11 Cr
FY 2024 · 10% margin
Associated legal entities of ubio
ubio is associated with 2 registered companies on The Company Check; the primary company is Ubio Biotechnology Systems Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ubio Biotechnology Systems Private Limited CIN U72200KL2008PTC022851 | Active | 23 Jul 2008 | Ernakulam, Kerala | ₹11.6 Cr | 3 | View details | |
| Ivet Labs Llp CIN AAR-9580 | Active | 18 Feb 2020 | Ernakulam, Kerala | 3 | View details |
Apps and channels of ubio
its YouTube channel ubiotec has 63 subscribers and 7 videos.
Videos from ubio
The most watched videos on ubio's YouTube channel, ubiotec (63 subscribers). Click a video to play it here.
More on ubiotec.
Board of directors of Ubio Biotechnology Systems Private Limited (ubio)
Ubio Biotechnology Systems Private Limited is the primary company behind ubio. The boards of the 2 registered companies of ubio currently have 5 directors; the longest-serving is Brij Krishen Qasba, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Brij Krishen Qasba DIN 00190638 | Whole-time director | 28 Feb 2014 | 12 yrs 7 mo | Ubio Biotechnology Systems Private Limited |
| Ravinder Qasba DIN 02897800 | Director | 28 Feb 2014 | 12 yrs 7 mo | Ubio Biotechnology Systems Private Limited |
| Noushad Tholantakath DIN 08702940 | Designated Partner | 18 Feb 2020 | 6 yrs 8 mo | Ivet Labs Llp |
| Bishor Ibrahim Varakukalayil DIN 02163198 | Designated Partner | 18 Feb 2020 | 6 yrs 8 mo | Ivet Labs Llp, Ubio Biotechnology Systems Private Limited |
| Vysakh Mattummal Valappil DIN 08497790 | Designated Partner | 04 May 2022 | 4 yrs 5 mo | Ivet Labs Llp |
People of ubio
1 people are tracked at ubio (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & Managing Director | Leadership |
Complete people profiles for ubio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of ubio
Figures of Ubio Biotechnology Systems Private Limited, the primary company behind ubio, for FY 2024. Revenue was ₹11.58 Cr (+66% year on year). Net profit was ₹16 Lakh (1% margin). EBITDA was ₹1.11 Cr (10% margin). Revenue has grown at a compounded annual rate of -6% over three years and +35% over five years.
- ₹11.58 CrRevenue · FY 2024 · +66% YoY
- ₹16 LakhNet profit · 1% margin
- ₹1.11 CrEBITDA · 10% margin
- ₹1.43 CrPaid-up capital
- -6%Revenue CAGR, 3 years
- +35%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ubio Biotechnology Systems Private Limited are on its company page.
Detailed financial statements for ubio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of ubio
The website of ubio (ubio.in) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 7.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ubio
Complete news archive for ubio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ubio
ubio was founded in 2008.
ubio is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
The primary company behind ubio, Ubio Biotechnology Systems Private Limited, reported revenue of βΉ11.58 Cr for FY 2024, up 66% year on year.
ubio is a diagnostic company developing medical, veterinary and food diagnostics products. The company majorly focused on immunochromatographic based lateral flow devices. It has developed rapid test kits for infections (filariasis, thyroid, brucellosis, cholera, rotavirus, adenovirus, H. pyroli, HIV, Hepatitis), biomarkers hormones for the human. The company has also developed immunoassays for livestock poultry. The company is developing assays based on serology, biochemistry molecular diagnostics and diagnostic equipment. Also offering contract manufacturing, contract assay development consulting services for diagnostic applications.
ubio is associated with 2 legal entities: Ubio Biotechnology Systems Private Limited, Ivet Labs Llp.
The legal entities of ubio currently have 6 directors, including Noushad Tholantakath, Vysakh Mattummal Valappil, Bishor Ibrahim Varakukalayil and others.
